Westlake Chemical Corp. on Aug. 31 completed its acquisition of Axiall Corp. for a transaction value of $3.69 billion.
The company offered $33 per share for the stake.
In addition to general closing conditions, the deal required additional review for antitrust concerns.
Deutsche Bank AG and Goldman Sachs & Co. LLC were the financial advisers for Westlake Chemical, and Cleary Gottlieb Steen & Hamilton LLP, Morris Nichols Arsht & Tunnell LLP and Potter Anderson & Corroon LLP were the legal advisers.
Barclays Capital Inc. and Morgan Stanley & Co. LLC were the financial advisers for Axiall, while Jones Day, Richards Layton & Finger P.A. and Weil Gotshal & Manges LLP were the legal advisers.